NCT07209852招募中不适用
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up (SEPTA PMCF)
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 140
- 试验地点
- 13
- 主要终点
- LBBA Implant Success Rate
研究概览
简要总结
The goal of this observational post-market clinical Follow-up study is to learn about the long-term safety, performance, and clinical benefits of pacing the left bundle branch area (LBBAP) using the INGEVITY+ pacemaker lead in patients with bradycardia who need a pacemaker.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects intended to undergo initial (de novo) pacing system implant using the INGEVITY+ lead in the left bundle branch area (LBBA) and a Boston Scientific single or dual- chamber pacemaker (Note: no prior attempted pacing system components);
- •Subjects who are indicated for and will receive a Boston Scientific pacemaker system (including the single or dual chamber pacemaker and an INGEVITY+ lead in the LBBA location) for one of the following medical conditions:
- •Symptomatic paroxysmal or permanent second- or third-degree AV block,
- •Symptomatic bilateral bundle branch block,
- •Symptomatic paroxysmal or transient sinus node dysfunction with or without associated AV conduction disorders (i.e., sinus bradycardia, sinus arrest, sinoatrial [SA] block),
- •Bradycardia-tachycardia syndrome, to prevent symptomatic bradycardia or some forms of symptomatic tachyarrhythmias,
- •Neurovascular (vasovagal) syndromes or hypersensitive carotid sinus syndromes,
- •Adaptive-rate pacing for patients exhibiting chronotropic incompetence and who may benefit from increased pacing rates concurrent with increases in minute ventilation and/or level of physical activity.
- •Dual-chamber and atrial tracking modes are also indicated for patients who may benefit from maintenance of AV synchrony. Dual chamber modes are specifically indicated for treatment of the following:
- •Conduction disorders that require restoration of AV synchrony, including varying degrees of AV block,
- •VVI intolerance (i.e., pacemaker syndrome) in the presence of persistent sinus rhythm,
- •Low cardiac output or congestive heart failure secondary to bradycardia;
- •Subjects willing and capable of providing informed consent and participating in all testing and clinic visits associated with the clinical study at an approved clinical study location and at the intervals defined by protocol;
- •Subjects who are ≥18 years of age, and of legal age to give informed consent specific to state and national law.
排除标准
- •Subjects meeting guideline indications for cardiac resynchronization therapy (CRT) in the absence of a bradycardia indication;
- •Subjects with a known or suspected sensitivity to dexamethasone acetate (DXA);
- •Subjects with a Mechanical Tricuspid Valve;
- •Subjects requiring hemodialysis or peritoneal dialysis;
- •Subject has or has had implanted any pacemaker, ICD system, including subcutaneous, transvenous or leadless systems (Note: except for temporary pacing wire at time of enrollment) or CRT system;
- •Subjects currently on an active organ transplant list;
- •Subject referred to or admitted for hospice care;
- •Subjects with a documented life expectancy of less than 12 months;
- •Subjects enrolled in any other concurrent study (unless prior approval is received from the Sponsor);
- •Subjects who are, or plan to become pregnant during the course of the study or are breastfeeding at time of enrollment;
- •Subjects who are unable or unwilling to comply with the follow-up schedule, including those living at such a distance from the investigational site that attending follow-up visits would be unusually difficult or burdensome.
研究组 & 干预措施
Patients receiving INGEVITY+ lead for left bundle branch area pacing
This group includes adult patients with bradycardia who are indicated for a Boston Scientific pacemaker system. All participants will undergo implantation of an INGEVITY+ pace/sense lead in the left bundle branch area (LBBAP) with a compatible Boston Scientific pacemaker.
干预措施: Pacemaker lead (Device)
结局指标
主要结局
LBBA Implant Success Rate
时间窗: At the time of implant procedure (Day 0).
Percentage of subjects in whom the INGEVITY+ lead is successfully implanted in the left bundle branch area (LBBA). Implant success is determined by ECG and procedural criteria, as defined per protocol.
Maintenance of Ventricular Synchrony (Paced QRS Duration)
时间窗: From implant through 3-year follow-up.
Mean paced QRS duration measured by 12-lead ECG to assess preservation of ventricular synchrony.
次要结局
未报告次要终点
研究者
研究点 (13)
Loading locations...
相似试验
招募中
不适用
Performance and Safety Assessment of SPRING THREAD® Elastic Tensor Thread in Patients with Mild to Moderate Facial Ptosis.PtosisPtosis, MildNCT057460781st SurgiConcept99
进行中（未招募）
不适用
Avenir® Cemented Hip Stem - PMCFPost-Traumatic Osteoarthritis of HipOsteotomiesSequelae From Previous Hip SurgeryPrimary OsteoarthritisFemoral Head NecrosisFemoral Neck FracturesCongenital Hip DysplasiaNCT03396224Zimmer Biomet100
Enrolling By Invitation
不适用
MDR Vivacit-E Elevated StudyOsteoarthritis (OA) of the HipAvascular Necrosis of Bone of HipProtrusio AcetabuliTraumatic Arthropathy-HipSlipped Capital Femoral EpiphysesFused HipFracture of PelvisDiastrophic VariantNCT07150221Zimmer Biomet52
已完成
不适用
LifeVest Safety and Efficacy in Real Life Settings in FranceLeft Ventricular DysfunctionCardiac ArrythmiasCardiac EventSudden Cardiac DeathNCT03319160Zoll Medical Corporation1,164
进行中（未招募）
不适用
Essilor® Stellest® Lenses Multicentre European Study (SLOMES)MyopiaNCT06263946Essilor International150